Literature DB >> 8189491

Analysis of AP-1 function in cellular transformation pathways.

T Suzuki1, M Murakami, N Onai, E Fukuda, Y Hashimoto, M H Sonobe, T Kameda, M Ichinose, K Miki, H Iba.   

Abstract

To understand the role of endogenous AP-1 activity in cellular transformation induced by oncogenes, we have made use of a fos mutant (supfos-1) and a jun mutant (supjun-1), either of which can function as a transdominant inhibitor of AP-1-mediated transcriptional regulation. Chicken embryo fibroblasts (CEF) infected with a series of transforming retroviruses were doubly infected with retrovirus carrying supfos-1 or supjun-1, and suppression of cellular transformation was monitored in terms of reversion to normal cellular morphology or acquisition of anchorage-dependent growth. Cellular transformation induced by several exogenously expressed transforming genes of the fos or jun family was efficiently suppressed, as expected. CEF transformed by v-src, v-yes, v-fps, c-Ha-ras, and N-terminally truncated c-raf were also induced to revert to the normal phenotype by these transdominant mutants, suggesting that functional transcription factor AP-1 activity is essential for the cellular transformation induced by these oncogenes. The suppression is not attributable to nonspecific inhibition of cellular proliferation, because CEF transformed by v-ros or v-myc were not induced to revert to the normal phenotype. We next analyzed changes in all known components of chicken AP-1 induced by v-src, c-Ha-ras, or activated c-raf transformation. The levels of both Fra-2 and c-Jun expression were elevated two- to fourfold, and hyperphosphorylation of Fra-2 was also observed. We further showed that Fra-2-c-Jun heterodimer is mainly responsible for the elevated AP-1 DNA-binding activity in these transformed cells, and we propose that this heterodimer play a crucial role in the transformation induced by these oncogenes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8189491      PMCID: PMC236856     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Definition of the human raf amino-terminal regulatory region by deletion mutagenesis.

Authors:  V P Stanton; D W Nichols; A P Laudano; G M Cooper
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

2.  Transforming potential and growth stimulating activity of the v-fos and c-fos genes carried by avian retrovirus vectors.

Authors:  H Iba; Y Shindo; H Nishina; T Yoshida
Journal:  Oncogene Res       Date:  1988

3.  The chicken c-fos gene: cloning and nucleotide sequence analysis.

Authors:  K T Fujiwara; K Ashida; H Nishina; H Iba; N Miyajima; M Nishizawa; S Kawai
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

4.  Avian sarcoma virus 17 carries the jun oncogene.

Authors:  Y Maki; T J Bos; C Davis; M Starbuck; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

5.  Induction of protooncogene c-jun by serum growth factors.

Authors:  K Ryder; D Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

6.  fra-1: a serum-inducible, cellular immediate-early gene that encodes a fos-related antigen.

Authors:  D R Cohen; T Curran
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

7.  DNA binding activities of three murine Jun proteins: stimulation by Fos.

Authors:  Y Nakabeppu; K Ryder; D Nathans
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

8.  jun-D: a third member of the jun gene family.

Authors:  K Ryder; A Lanahan; E Perez-Albuerne; D Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

9.  Microinjection of fos-specific antibodies blocks DNA synthesis in fibroblast cells.

Authors:  K T Riabowol; R J Vosatka; E B Ziff; N J Lamb; J R Feramisco
Journal:  Mol Cell Biol       Date:  1988-04       Impact factor: 4.272

10.  The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity.

Authors:  M Zerial; L Toschi; R P Ryseck; M Schuermann; R Müller; R Bravo
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598

View more
  31 in total

1.  Pleiotropic action of AP-1 in v-Src-transformed cells.

Authors:  Lizhen Wang; Natalie A Rodrigues; Ying Wu; Bart M Maslikowski; Nishi Singh; Samantha Lacroix; Pierre-André Bédard
Journal:  J Virol       Date:  2011-04-20       Impact factor: 5.103

2.  Characterization of ATF2 in Rel/NFκB oncogenesis reveals its role in the regulation of Ras signaling.

Authors:  Andrew S Liss; Henry R Bose
Journal:  Small GTPases       Date:  2011-03

3.  AP-1 factors play an important role in transformation induced by the v-rel oncogene.

Authors:  J Kralova; A S Liss; W Bargmann; H R Bose
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

4.  Autocrine growth and anchorage independence: two complementing Jun-controlled genetic programs of cellular transformation.

Authors:  H van Dam; S Huguier; K Kooistra; J Baguet; E Vial; A J van der Eb; P Herrlich; P Angel; M Castellazzi
Journal:  Genes Dev       Date:  1998-04-15       Impact factor: 11.361

5.  Nerve growth factor, but not epidermal growth factor, increases Fra-2 expression and alters Fra-2/JunD binding to AP-1 and CREB binding elements in pheochromocytoma (PC12) cells.

Authors:  V Boss; J D Roback; A N Young; L J Roback; D M Weisenhorn; R Medina-Flores; B H Wainer
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

6.  Regulation of gene expression by the small GTPase Rho through the ERK6 (p38 gamma) MAP kinase pathway.

Authors:  M J Marinissen; M Chiariello; J S Gutkind
Journal:  Genes Dev       Date:  2001-03-01       Impact factor: 11.361

7.  Immediate-early gene induction and MAP kinase activation during recovery from metabolic inhibition in cultured cardiac myocytes.

Authors:  A Yao; T Takahashi; T Aoyagi; K Kinugawa; O Kohmoto; S Sugiura; T Serizawa
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

Review 8.  Signal transduction and molecular targets of selected flavonoids.

Authors:  Ann M Bode; Zigang Dong
Journal:  Antioxid Redox Signal       Date:  2013-04-15       Impact factor: 8.401

9.  Cell transformation by c-fos requires an extended period of expression and is independent of the cell cycle.

Authors:  G G Miao; T Curran
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

10.  Cellular processes of v-Src transformation revealed by gene profiling of primary cells--implications for human cancer.

Authors:  Bart M Maślikowski; Benjamin D Néel; Ying Wu; Lizhen Wang; Natalie A Rodrigues; Germain Gillet; Pierre-André Bédard
Journal:  BMC Cancer       Date:  2010-02-12       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.